1/ A year ago, a 71-year-old Louisiana man died from H5N1, marking the first avian flu death in the US. Now we report in @JExpMed that the cause of his death is rogue autoantibodies neutralizing type I IFN (AutoAb-IFN). https://t.co/L3COz2taJR

Martins-Ferreira and @eballestar @CarrerasIJC review how ICF syndrome serves as a paradigm of epigenetic #immunodeficiency. They show how alterations in DNA methylation and chromatin remodeling disrupt genome stability and B cell maturation. https://t.co/hsFZ0Xa35p

In less than 8 months, @jhumimmunity has published 56 papers ( https://t.co/UvXYTJkp5z), including 10 already on PubMed ( https://t.co/N8TuO76CLp). Please submit studies of human inborn errors of immunity and their phenocopies ( https://t.co/siZ4v6J2rd) !

📣 Only one week left! Don’t miss the first-ever #JMFSpeakerSeries event, happening November 10, 2025, at 11 AM EST! Join us as we celebrate Vicki Modell’s legacy on her birthday with an inspiring conversation led by Dr. Lisa Forbes-Satter, featuring world-renowned immunology

Already 53 phenomenal papers published in the @jhumimmunity ! Look it up and submit your best papers to the only journal focused on human inborn errors of immunity, their phenocopies, and related topics in human immunology: https://t.co/UvXYTJkWV7

@CytokineSociety @Montse_JExpMed See our #Cytokines collection:

Werner, Mogensen et al. @AarhusUni identify genetically heterozygous and transcriptionally homozygous deficiency of IRF7 as an inborn error of interferon immunity underlying #herpesvirus CNS infection. https://t.co/2DMwBrzPMB #HumanDiseaseGenetics #Immunodeficiency

Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases

Original Article: Common Diseases in Clinical Cohorts — Not Always What They Seem https://t.co/PBk8feriL4 Editorial: A Rare-in-Common Paradigm for Precision Genomic Medicine https://t.co/wKXF0QInBB #Genetics

Have you considered submitting a paper to @jhumimmunity ? To know more about us, please read our inaugural editorial:

https://t.co/y6L8ZiFD5F has had a great ride and it's only been the beginning ! The seven enigmas of SARS-CoV-2: From the past to the future

In this review, Andreakos et al. report the progress of the COVID Human Genetic Effort since its launch 5 years ago, with the aim to understand clinical variability, from resistance to severe outcomes, among individuals exposed to #SARSCoV2. https://t.co/jRwUBCIl12 #COVID19

Thank you @LASIDimmuno - and congratulations on a heart- and brainwarming meeting!

Silvia Sanchez Ramon takes us to the world of secondary immunodeficiency!

Angelo de Quadros shows us more about STAT1 GOF and ruxolitinib! @lasidjuniors #lasid2025

Our very own @cecipolih navigates through the immune dysregulation pathways at LASID 2025 #lasid2025

LASID’s tribute to wonderful , kind, strong and empowering Vicky Modell @Info4PI thanks so much Vanessa for everything you do and for being with us today and always!

Joel Mokyr, Philippe Aghion and Pewter Howitt share economics prize for work that underlines the importance of investing in research and development. https://t.co/dA1CnxpUNe

Nobel Prizes This Year Offer Three Cheers for Slow Science https://t.co/lhXKWctjx0 via @NYTimes. Slow science - curiosity driven research - for the ultimate benefit of humanity

It’s International #PlasmaAwarenessWeek! 💙 Plasma is powerful. From saving the lives of PI patients to treating neurological and autoimmune conditions, plasma-derived therapies are essential. Yet, less than 5% of eligible people donate plasma—and patients need thousands of